4.2 Article

Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation

Yan Chang et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)

Article Pharmacology & Pharmacy

CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer

Sheng-Chang Wang et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)

Article Infectious Diseases

Drug Treatment as HIV Prevention: Expanding Treatment Options

David S. Metzger et al.

Current HIV/AIDS Reports (2010)

Article Substance Abuse

Development of the treatment outcomes profile

John Marsden et al.

ADDICTION (2008)

Article Anesthesiology

Role of CYP2B6 in stereoselective human methadone metabolism

Rheem A. Totah et al.

ANESTHESIOLOGY (2008)

Article Pharmacology & Pharmacy

Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

Xiao-Yan Qiu et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Review Anesthesiology

Actual and potential drug interactions associated with methadone

Douglas J. Weschules et al.

PAIN MEDICINE (2008)

Article Pharmacology & Pharmacy

ABCB1 and cytochrome P450 genotypes and phenotypes:: Influence on methadone plasma levels and response to treatment

Severine Crettol et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)

Article Biochemistry & Molecular Biology

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization

Hsiang-Yu Yuan et al.

NUCLEIC ACIDS RESEARCH (2006)

Article Pharmacology & Pharmacy

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

S Crettol et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)

Review Medical Laboratory Technology

Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications

J Tost et al.

CLINICAL BIOCHEMISTRY (2005)

Article Biochemical Research Methods

Chiral analysis of methadone and its major metabolites (EDDP and EMDP) by liquid chromatography-mass spectrometry

T Kelly et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)

Article Biochemical Research Methods

Haploview: analysis and visualization of LD and haplotype maps

JC Barrett et al.

BIOINFORMATICS (2005)

Article Pharmacology & Pharmacy

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

ED Kharasch et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)

Article Pharmacology & Pharmacy

Methadone - metabolism, pharmacokinetics and interactions

A Ferrari et al.

PHARMACOLOGICAL RESEARCH (2004)

Article Pharmacology & Pharmacy

Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro

JS Wang et al.

DRUG METABOLISM AND DISPOSITION (2003)

Article Psychology, Clinical

The clinical opiate withdrawal scale (COWS)

DR Wesson et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2003)

Article Genetics & Heredity

A comparison of Bayesian methods for haplotype reconstruction from population genotype data

M Stephens et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)